A Patient with Metastatic Microsatellite Instability-High Pancreatic Ductal Adenocarcinoma with a Prolonged Response to Single-Agent Pembrolizumab
Immunotherapy is an effective new approach in the treatment of many malignancies. However, pancreatic ductal adenocarcinoma (PDAC) does not usually respond to immunotherapy. We discuss the case of a patient with metastatic microsatellite instability-high PDAC who had a prolonged response to single-agent pembrolizumab for almost 3 years.
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
A Patient with Metastatic Microsatellite Instability-High Pancreatic Ductal Adenocarcinoma with a Prolonged Response to Single-Agent Pembrolizumab ; volume:14 ; number:3 ; year:2021 ; pages:1414-1417 ; extent:4
Case reports in oncology ; 14, Heft 3 (2021), 1414-1417 (gesamt 4)
- Urheber
-
Guedikian, Annie A.
Randall, Megan E.
Sharko, Anita
Leslie, William T.
- DOI
-
10.1159/000519181
- URN
-
urn:nbn:de:101:1-2022011223451625098518
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Guedikian, Annie A.
- Randall, Megan E.
- Sharko, Anita
- Leslie, William T.
Ähnliche Objekte (12)
Pembrolizumab response in stage IV luminal-type breast cancer with high microsatellite instability: a case report
A Case of Full Recovery from Prolonged Cardiac Arrest after Infusion with Paclitaxel and Pembrolizumab
Near complete response to Pembrolizumab in microsatellite-stable metastatic sebaceous carcinoma
Conversion surgery for microsatellite instability-high gastric cancer with a complete pathological response to pembrolizumab: a case report
Pembrolizumab
Immunogenicity of pembrolizumab in patients with advanced tumors
Complete Response to Pembrolizumab in a Patient with Castration-Resistant Prostate Cancer with Both BRCA Positivity and a High Frequency of Microsatellite Instability: A Case Report
Exceptional Regression of Malignant Pleural Mesothelioma with Pembrolizumab Monotherapy
Durable Response with Single-Agent Pembrolizumab in a Patient with Metastatic Melanoma
Prolonged Time from Diagnosis to Breast-Conserving Surgery is Associated with Upstaging in Hormone Receptor-Positive Invasive Ductal Breast Carcinoma
Medullary colon carcinoma with microsatellite instability: case report
SnoN expression is differently regulated in microsatellite unstable compared with microsatellite stable colorectal cancers
Pembrolizumab response in stage IV luminal-type breast cancer with high microsatellite instability: a case report
A Case of Full Recovery from Prolonged Cardiac Arrest after Infusion with Paclitaxel and Pembrolizumab
Near complete response to Pembrolizumab in microsatellite-stable metastatic sebaceous carcinoma
Conversion surgery for microsatellite instability-high gastric cancer with a complete pathological response to pembrolizumab: a case report
Pembrolizumab
Immunogenicity of pembrolizumab in patients with advanced tumors
Complete Response to Pembrolizumab in a Patient with Castration-Resistant Prostate Cancer with Both BRCA Positivity and a High Frequency of Microsatellite Instability: A Case Report
Exceptional Regression of Malignant Pleural Mesothelioma with Pembrolizumab Monotherapy
Durable Response with Single-Agent Pembrolizumab in a Patient with Metastatic Melanoma
Prolonged Time from Diagnosis to Breast-Conserving Surgery is Associated with Upstaging in Hormone Receptor-Positive Invasive Ductal Breast Carcinoma
Medullary colon carcinoma with microsatellite instability: case report
SnoN expression is differently regulated in microsatellite unstable compared with microsatellite stable colorectal cancers
Pembrolizumab response in stage IV luminal-type breast cancer with high microsatellite instability: a case report
A Case of Full Recovery from Prolonged Cardiac Arrest after Infusion with Paclitaxel and Pembrolizumab
Near complete response to Pembrolizumab in microsatellite-stable metastatic sebaceous carcinoma
Conversion surgery for microsatellite instability-high gastric cancer with a complete pathological response to pembrolizumab: a case report
Pembrolizumab
Immunogenicity of pembrolizumab in patients with advanced tumors
Complete Response to Pembrolizumab in a Patient with Castration-Resistant Prostate Cancer with Both BRCA Positivity and a High Frequency of Microsatellite Instability: A Case Report
Exceptional Regression of Malignant Pleural Mesothelioma with Pembrolizumab Monotherapy
Durable Response with Single-Agent Pembrolizumab in a Patient with Metastatic Melanoma
Prolonged Time from Diagnosis to Breast-Conserving Surgery is Associated with Upstaging in Hormone Receptor-Positive Invasive Ductal Breast Carcinoma
Medullary colon carcinoma with microsatellite instability: case report